JonathanThomasMegerianMD

PubMed

• 361 citations
  Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients With Symptomatic Intracranial Stenosis The VISSIT Randomized Clinica...
  Osama O. Zaidat, Brian-Fred Fitzsimmons, Britton Keith Woodward, Zhigang Wang, Monika Killer-Oberpfalzer
  JAMA. 2015-03-24
• 6 citations
  Review of Machine Learning and Artificial Intelligence (ML/AI) for the Pediatric Neurologist.
  Grace Y Gombolay, Nakul Gopalan, Andrea Bernasconi, Rima Nabbout, Jonathan T Megerian
  Pediatric Neurology. 2023-04-01
• 35 citations
  Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts.
  Scott L. Parker, William N. Anderson, Sean Lilienfeld, J. Thomas Megerian, Matthew J. McGirt
  Journal of Neurosurgery. Pediatrics. 2011-09-01

Journal Articles

• Melatonin Deficiency and Disrupted Circadian Rhythms in Pediatric Survivors of Craniopharyngioma.  
  Lipton J, Megerian JT, Kothare, SV, et al, Neurology, 7/28/2009
• Utility of Nerve Conduction Studies for Medicine Physicians  
  Megerian, J.T, Kong, X. and Gozani, S. N., J Am Board Fam Med, 1/1/2007
• "Diabetic Nerve Conduction Abnormalities in the Primary Care Setting"  
  Vinik, A.I., Kong, X, Megerian, J.T., Gozani, S.N., Diabetes Technology & Therapeutics, 12/1/2006
• Relative Diagnostic Utility of F-wave Latency Parameters.  
  Megerian, J.T., Kong, X., Gozani, S.N., Muscle Nerve, 10/1/2006
• Diagnostic Utility of F-wave Latency (FWL) Parameters in Lumbosacral Radiculopathy And Polyneuropathy.  
  Kong, X., Megerian, J.T., and Gozani, S.N., Muscle Nerve, 10/1/2006
• Repeatability of Nerve Conduction Measurements Using Automation. Journal of Clinical Monitoring and Computing.  
  Kong, X., Lesser, E.A., Megerian, J.T., Gozani, S.N., J Clin Monit Comput., 9/1/2006
• NC-stat as a Screening Tool for Carpal Tunnel Syndrome.  
  Megerian JT, Kong X, Lesser E, Gozani SN, J Occup Environ Med, 8/1/2006
• "Upper Extremity Nerve Conduction Studies in Diabetic Patients with the NC-stat."  
  Megerian, J.T., Gozani, S.N., Diabetes Technology & Therapeutics, 4/1/2006
• "Peroneal F-wave Characteristics under submaximal stimulation."  
  Kong, X, Bansal, P, Megerian, JT, Gozani,, Neurology, Neurophysiology and Neuroscience, 1/1/2006
• "Electrodiagnostic automation: principles and practice."  
  Gozani, S. N., M. A. Fisher, et al., Phys Med Rehabil Clin N Am, 1/1/2005
• Risk Factors for Nerve Conduction Confirmed Diabetic Peripheral Neuropathy in the Community Clinical Setting: A study of 100 patients.  
  Megerian, JT, Gozani, SN, Diabetes, 6/1/2004
• Automated nerve conduction testing technology to assess peripheral nerve function in diabetic neuropathic pain patients during duloxetine treatment.  
  Gozani SN, Megerian JT, Waninger A, Xie J, Wernicke J., Diabetes, 6/1/2004
• Time Course and Predictors of Median Nerve Conduction After Carpal Tunnel Release.  
  Time Course and Predictors of Median Nerve Conduction After Carpal Tunnel Release., J Hand Surg., 5/1/2004
• Disrupted Circadian Rhythms in Children Treated for Craniopharyngioma.  
  Megerian, T, Chart, H, Ferber, R, Adler-Golden, L. Shanahan, T, Czeisler, C, Pomeroy SL., Ann Neurol, 1/1/2004
• Automated Nerve Conduction Measurments in Patients with Symptoms of Diabetic Peripheral Neuropathy.  
  Vinik, AI, Megerian, JT, Gozani, SN, Diab Technol Therap, 1/1/2004
• Homocystinuria Presenting As Psychosis In An Adolescent  
  Ryan, MM, Sidhu, RK, Alexander, J, Megerian, JT., J. Child Neuro, 1/1/2002
• Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children.  
  Heuschkel, RB, Menace, CC, Megerian, JT, Baird, AE, J Pediatr Gastroenterol Nutr., 1/1/2000
• Amyloid precursor protein is part of a family of extracellular matrix-like adhesive micro fibrils.Neurobiol.  
  Enam, S.A., Megerian, JT., Tsui, H-CT., Siman, R.G., & Klein, WL., Aging, 1/1/1990
• Soluble proteins from rat olfactory bulb support the survival an differentiation of cultured basal forebrain neurons  
  Lambert, MP, Megerian, T., Garden, G. & Klein, WL., Dev. Brain Res., 1/1/1988
• Point-Of-Service Nerve Conduction Studies: An Example of Industry-Driven Disruptive Innovation in Health Care.  
  Lesser, E.A., Starr, J., Kong, X, Megerian, J.T., and Gozani, S.N., Perspective in Biology and Medicine
• Join now to see all

Abstracts/Posters

• Recurrent encephalopathy with coma: An unusual late delayed effect of whole-brain radiotherapy.
  Megerian JT, Paleologos NA, Vick, Am Acad. Neurol, 1/1/1995
• Delayed Phosphorylation of GAP-43 During Neurite Outgrowth in a Mouse Neuroblastoma Line.
  Megerian, J.T., Meiri, K.F., & Klein, W.L., Soc.Neurosci., 1/1/1991
• Expression of Tau and ALZ-50 in Human Cortical Cell Line HCN-1A and Non-Human Neuroblastoma Cell Lines.
  Enam, S.A., Megerian, J.T., & Klein, W.L., Soc. Neurosci., 1/1/1991
• Evidence that neuromodulin (GAP- 43, B-50, pp46, F1) is not essential for early neuritogenesis.
  Megerian, JT, & Klein., WL, Soc.Neurosci., 1/1/1990
• GAP-43 expression without neurite extension
  Megerian, JT, Sullivan, JP & Klein, WL, Soc. Neurosci., 1/1/1989
• Soluble proteins from rat olfactory bulb support the survival an differentiation of cultured basal forebrain neurons
  Lambert, MP, Megerian, T., Garden, G. & Klein, WL., Soc. Neurosci., 1/1/1987
• Join now to see all

Lectures

• Autism: What Have We Learned and How to Manage 
  Children's Hospital Boston Pediatric Health Care Summit, Beverly, MA - 4/29/2009
• Alzheimer's Disease Treatment Update: Present and Future 
  Medical Grand Rounds, North Shore Medical Center; Medical Grand Rounds, Union Hospital, Jun 2009 - 3/13/2009
• Pipeline Projects Session. Results from a Phase 2A clinical study of a novel 5HT4 agonist for the treatment of Alzheimer's Disease. 
  American Society for Experimental Neurotherapeutics Annual Meeting, Arlington, VA - 3/6/2009
• Hot Topic Presentation: Results of a Phase 2A study of PRX-03140 For The Treatment of Alzheimer's Disease 
  International Conference on Alzheimer's Disease (ICAD), Chicago, IL - 7/30/2008
• Neurobiology to Neurodegenerative Diseases & Therapeutics: "In Silico to Patient; A case study in expedited drug development for Alzheimers Disease" 
  First International Neuron to Synapse Meeting, Boston, MA - 5/27/2008
• "ADHD: How to Manage in the Office and When to Refer" 
  Childrens Hospital Pediatric Health Care Summit at South Shore Hospital, Weymouth, MA - 5/17/2008
• "Results of a Phase 2A Study of a Novel 5HT4 Agonist for the Treatment of Alzheimer's Disease" 
  Keystone Symposia Alzheimer's Disease Meeting, Keystone, CO - 3/28/2008
• "Tics, Tourettes and Pandas" 
  Pediatric Grand Rounds, Lowell General Hospital, Lowell, MA - 10/23/2007
• "A New Paradigm in Drug Discovery and Development: A Case Study with PRX-03140" 
  12th Annual Drug Discovery & Development of Innovative Therapeutics, CNS Drug Discovery and Developm - 8/1/2007
• Join now to see all

Other

• Results of a Phase 2A Study of PRX-03140 For the Treatment of Alzheimer's disease. 
  Megerian, J.T., Shacham, S, Kalafer, M, and Uprichard, A., ICAD, Blog
  Chicago, IL - 7/1/2008
• CELLULAR AND MOLECULAR CORRELATES OF NEURITOGENESIS: MOLECULES REGULATING GROWTH CONE BEHAVIOR AND NEURITE OUTGROWTH. 
  Megerian, J. T., Dissertation
  Northwestern University Medical School - 1/1/1993